Back to search
Haploidentical Hematopoietic Stem Cell Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Haploidentical Hematopoietic Stem Cell Transplantation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Haploidentical Hematopoietic Stem Cell Transplantation trials you may qualify forBackground: Allogeneic hematopoietic stem cell transplant involves taking blood stem cells from a donor and giving them to a recipient. The transplants are use…
Background: \- GATA2 deficiency is a disease caused by mutations in the GATA2 gene. It can cause different types of leukemia and other diseases. Researchers wa…
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), significantly affecting survival…
Background: People living with HIV(PLWH) are at a higher risk for cancers that may be curable with a bone marrow transplant. HIV infection itself is no longer…
This trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentica…
Background: During a transplant, blood stem cells from one person are given to someone else. The cells grow into the different cells that make up the immune sy…
Background: Some blood cancers can be caused by germline variants (changes) in a person s RUNX1 gene. Germline variants are genetic inherited changes a person…
This is a prospective, single-center, observational study to evaluate the efficacy and safety of salvage haploidentical allogeneic hematopoietic stem cell trans…